Dusseldorf - Delayed Quote • EUR Celyad Oncology (1C0.DU) Follow Add holdings 0.3620 -0.0080 (-2.16%) At close: 8:10:04 AM GMT+2 Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure Undo Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for 1C0.DU 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: 1C0.DU View More All News Press Releases SEC Filings Celyad Oncology Reports Full Year 2024 Financial Results and Recent Business Highlights Celyad Oncology announces the publication of the preclinical and clinical data of CYAD-211 providing proof-of-concept of its miRNA-based shRNA platform Celyad Oncology to Present at the 2024 SITC Annual Meeting Celyad Oncology Announces Appointment of Matt Kane as Chief Executive Officer Celyad Oncology Reports First Half Year 2024 Financial Results and Recent Business Highlights